Abiopharma

🔍 Grawey Nathaniel A. (Executive)

Company: Tenon Medical, Inc. (TNON)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 68,201 shares of Common stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 243,584.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common stock (Direct)
  Date: 2026-05-01 | Code: H | shares_owned_after: 239,281.00

Footnotes:

• F1: On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 24.69% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.